Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
IN8bio, Inc. (INAB) had Normalized Income after Taxes of $-5.55M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-5.55M |
|
-- |
|
-- |
|
$5.66M |
|
$-5.66M |
|
$0.11M |
|
$-5.55M |
|
$-5.55M |
|
$-5.55M |
|
$-5.55M |
|
$-5.55M |
|
|
Normalized Income after Taxes |
$-5.55M |
$-5.66M |
|
$-4.99M |
|
83.48M |
|
83.48M |
|
$-0.07 |
|
$-0.07 |
|
| Balance Sheet Financials | |
$12.72M |
|
$2.60M |
|
$7.14M |
|
$19.87M |
|
$2.96M |
|
$0.19M |
|
$3.04M |
|
$5.99M |
|
$13.88M |
|
$13.88M |
|
$13.88M |
|
81.26M |
|
| Cash Flow Statement Financials | |
$-3.12M |
|
-- |
|
$3.89M |
|
$11.39M |
|
$12.16M |
|
$0.77M |
|
$0.83M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.30 |
|
-- |
|
-- |
|
0.01 |
|
0.06 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.12M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-39.99% |
|
-39.99% |
|
-27.93% |
|
-39.46% |
|
$0.17 |
|
$-0.04 |
|
$-0.04 |
|